Description

MOTS-c Nasal Spray

MOTS-c
CAS Number	1627580-64-6
Molar Mass	2174.7 g/mol
Chemical Structure	C101H152N28O22S2
IUPAC Name	H-Met-Arg-Trp-G

Introduction

Introducing top-tier Nasal Sprays meticulously crafted for research endeavors, showcasing the remarkable MOTS-c peptide. This product boasts exceptional qualities, a wide range of applications, and numerous benefits across various research scenarios, establishing itself as an invaluable tool for scientific exploration.

Key Characteristics

MOTS-c Sprays exhibit exceptional purity and consistency, providing researchers with a reliable tool for their studies. The product is designed exclusively for research purposes and should not be considered for human consumption.

Research Applications

The versatility of MOTS-c makes it applicable to various research areas. Researchers can explore its effects on cellular function, metabolism, and other physiological processes.

Research Benefits

MOTS-c and Longevity

Numerous research studies suggest a potential link between MOTS-c and longevity. Investigations into cellular aging and lifespan extension have shown promising results, indicating MOTS-c’s role as a key player in these processes.

MOTS-c and Obesity

Studies in the realm of obesity research have highlighted MOTS-c’s impact on metabolic regulation. The peptide demonstrates potential benefits in mitigating obesity-related factors, making it a subject of interest for researchers exploring novel approaches to address this global health concern.

MOTS-c and Fatty Acids

Research indicates that MOTS-c may influence fatty acid metabolism. This has implications for understanding the peptide’s role in energy regulation and may open avenues for investigating its potential therapeutic applications in conditions related to lipid metabolism.

Summary

MOTS-c Nasal Spray offer a valuable resource for researchers delving into the intricate realms of longevity, obesity, and fatty acid metabolism. With its meticulously designed formulation, this research product stands as a crucial tool in advancing scientific understanding and exploring potential applications of the MOTS-c peptide.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Fuku N, Pareja-Galeano H, Zempo H, Alis R, Arai Y, Lucia A, Hirose N. The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity? Aging Cell. 2015 Dec;14(6):921-3. doi: 10.1111/acel.12389. Epub 2015 Aug 20. PMID: 26289118; PMCID: PMC4693465. [Read More]
2. Du C, Zhang C, Wu W, Liang Y, Wang A, Wu S, Zhao Y, Hou L, Ning Q, Luo X. Circulating MOTS-c levels are decreased in obese male children and adolescents and associated with insulin resistance. Pediatr Diabetes. 2018 Apr 25. doi: 10.1111/pedi.12685. Epub ahead of print. PMID: 29691953. [Read More]
3. Kim SJ, Miller B, Mehta HH, Xiao J, Wan J, Arpawong TE, Yen K, Cohen P. The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity. Physiol Rep. 2019 Jul;7(13):e14171. doi: 10.14814/phy2.14171. PMID: 31293078; PMCID: PMC6640593. [Read More]